ArticleEndocrinology, diabetes & metabolism2025
The Effect of Hyperoxia on Nitric Oxide Metabolism in the Skeletal Muscle of Male Type 2 Diabetic Rats.
Article in Endocrinology, diabetes & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Effect of Hyperoxia on Nitric Oxide Metabolism in the Skeletal Muscle of Male Type 2 Diabetic Rats.Endocrinology, diabetes & metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionHypoxia is involved in the pathophysiology of type 2 diabetes (T2D), and oxygen therapy (hyperoxia) has been proposed for managing T2D. As a side effect, hyperoxia increases nitric oxide (NO) metabolism and decreases NO bioavailability. This study aims to investigate the effect of hyperoxia on NO synthases (NOSs), which produce NO from L-arginine and arginase, which degrades L-arginine in the soleus muscle (SM) of rats with T2D.
methodsA combined high-fat diet and a low dose of streptozotocin (30 mg/kg) were used to induce T2D in rats. Rats with T2D were divided into four groups (n = 6/group): Control rats exposed to normoxia (Control), control rats exposed to hyperoxia (C + HOX), diabetic rats exposed to normoxia (T2D) and diabetic rats exposed to hyperoxia (T2D + HOX). The hyperoxia and the control groups received 95% and 21% oxygen for 35 days, respectively. SM was isolated at day 35, and the protein levels of endothelial NOS (eNOS), inducible NOS (iNOS), arginase, as well as tissue concentrations of lactate and NO metabolites (nitrate+nitrite = NOx) were measured.
resultsCompared to T2D, T2D + HOX rats had lower lactate concentration by 38% (p = 0.009) and NOx concentration by 23% (p = 0.011) in SM. In SM of rats with T2D, hyperoxia decreased eNOS protein by 46.2% (1.4 ± 0.13 vs. 2.6 ± 0.2 ng/mg protein, p = 0.002) and increased arginase protein by 2.3-fold (1.04 ± 0.05 vs. 0.31 ± 0.07 ng/mg protein, p < 0.001) but did not affect iNOS protein. Hyperoxia did not affect lactate concentration, eNOS and iNOS in SM of control rats but decreased NOx concentration by 25% (p = 0.003).
conclusionHyperoxia decreased NO bioavailability in SM of rats with T2D; this effect was associated with decreased eNOS and increased arginase protein levels. These findings suggest that oxygen therapy in diabetic rats may decrease NO bioavailability as a potential side effect.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.